Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M201563200 on April 15, 2002

J. Biol. Chem., Vol. 277, Issue 26, 23733-23741, June 28, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/26/23733    most recent
M201563200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robichaud, G. A.
Right arrow Articles by Tremblay, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robichaud, G. A.
Right arrow Articles by Tremblay, M. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Nuclear Factor of Activated T Cells Is a Driving Force for Preferential Productive HIV-1 Infection of CD45RO-expressing CD4+ T Cells*

Gilles A. RobichaudDagger §, Benoit BarbeauDagger §||, Jean-François Fortin**, David M. RothsteinDagger Dagger , and Michel J. TremblayDagger §§

From the Dagger  Centre de Recherche en Infectiologie, Hôpital du Centre Hospitalier de L'Université Laual, Centre Hospitalier Universitaire de Québec, and Département de Biologie médicale, Faculté de Médecine, Université Laval, Ste-Foy, Québec G1V 4G2, Canada, the ** Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, California 94305-5175, the Dagger Dagger  Department of Medicine, Yale Medical School, New Haven, Connecticut 06520

Human immunodeficiency virus type-1 (HIV-1) preferentially replicates in CD4-expressing T cells bearing a "memory" (CD45RO+) rather than a "naive" (CD45RA+/CD62L+) phenotype. Yet the basis for the higher susceptibility of these cells to HIV-1 infection remains unclear. Because the nature of the CD45 isoform itself can affect biochemical events in T cells, we set out to determine whether these isoforms could differently modulate HIV-1 long terminal repeat (LTR) activity and thereby replication. Through the use of CD4+ Jurkat T cells specifically expressing distinct CD45 isoforms (i.e. CD45RABC or CD45RO), we demonstrated that a difference in CD45 isoform expression conferred preferential replication of HIV-1 to CD45RO-expressing T cell clones following a physiological CD3/CD28 stimulation. Closer analysis indicated that higher HIV-1 LTR activation levels were consistently observed in CD45RO-positive cells, which was paralleled by more pronounced nuclear factor of activated T cells (NFAT) activation in these same cells. Specific involvement of NFAT1 was revealed in studied Jurkat clones by mobility shift analyses. In addition, preferential activation of the LTR and viral replication in CD45RO T cells was FK506- and cyclosporin A-sensitive. These results underscore the importance of NFAT in HIV-1 regulation and for the first time identify the role of the CD45 isoform in limiting productive HIV-1 replication to the human CD4 memory T cell subset.


* This study was supported by grants (to M. J. T.) from the Canadian Institutes of Health Research (CIHR) HIV/AIDS Research Program (Grants HOP-14438, HOP-15575, and MOP-37781) and by the National Institutes of Health (AI36317 and AI 45485) (to D. M. R.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These authors have contributed equally to this work.

This work was performed by G. A. R. in partial fulfillment of the Ph.D. degree from the Microbiology-Immunology Program, Faculty of Medicine, Laval University. G. A. R. was the recipient of a Ph.D. Fellowship from the Fonds de la Recherche en Santé du Québec/Fonds pour la Formation de Chercheurs et l'Aide à la Recherche-Program Santé.

|| Holds a Scholarship Award (Junior 1 level) from the Fonds de la Recherche en Santé du Québec.

§§ Recipient of a Tier 1 Canada Research Chair in Human Immuno-Retrovirology. To whom correspondence should be addressed: Laboratoire d'Immuno-Rétrovirologie Humaine, Centre de Recherche en Infectiologie, RC709, Hôpital du Centre Hospitalier de L'Université Laual, Centre Hospitalier Universitaire de Québec, 2705 Boul. Laurier, Ste-Foy, Québec G1V 4G2, Canada. Tel.: 418-654-2705; Fax: 418-654-2212; E-mail: michel.j.tremblay@crchul.ulaval.ca.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
R. Alvarez, J. Reading, D. F. L. King, M. Hayes, P. Easterbrook, F. Farzaneh, S. Ressler, F. Yang, D. Rowley, and A. Vyakarnam
WFDC1/ps20 Is a Novel Innate Immunomodulatory Signature Protein of Human Immunodeficiency Virus (HIV)-Permissive CD4+ CD45RO+ Memory T Cells That Promotes Infection by Upregulating CD54 Integrin Expression and Is Elevated in HIV Type 1 Infection
J. Virol., January 1, 2008; 82(1): 471 - 486.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Thibault, M. R. Tardif, C. Barat, and M. J. Tremblay
TLR2 Signaling Renders Quiescent Naive and Memory CD4+ T Cells More Susceptible to Productive Infection with X4 and R5 HIV-Type 1
J. Immunol., October 1, 2007; 179(7): 4357 - 4366.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M.-O. Kim, H.-S. Suh, Q. Si, B. I. Terman, and S. C. Lee
Anti-CD45RO Suppresses Human Immunodeficiency Virus Type 1 Replication in Microglia: Role of Hck Tyrosine Kinase and Implications for AIDS Dementia
J. Virol., January 1, 2006; 80(1): 62 - 72.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. R. Tardif and M. J. Tremblay
LFA-1 Is a Key Determinant for Preferential Infection of Memory CD4+ T Cells by Human Immunodeficiency Virus Type 1
J. Virol., November 1, 2005; 79(21): 13714 - 13724.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Choi, J. Walker, K. Talbert-Slagle, P. Wright, J. S. Pober, and L. Alexander
Endothelial Cells Promote Human Immunodeficiency Virus Replication in Nondividing Memory T Cells via Nef-, Vpr-, and T-Cell Receptor-Dependent Activation of NFAT
J. Virol., September 1, 2005; 79(17): 11194 - 11204.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A.-M. Lemieux, M.-E. Pare, B. Audet, E. Legault, S. Lefort, N. Boucher, S. Landry, T. van Opijnen, B. Berkhout, M. H. Naghavi, et al.
T-cell Activation Leads to Poor Activation of the HIV-1 Clade E Long Terminal Repeat and Weak Association of Nuclear Factor-{kappa}B and NFAT with Its Enhancer Region
J. Biol. Chem., December 17, 2004; 279(51): 52949 - 52960.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Williams{section}, L.-F. Chen, H. Kwon, D. Fenard, D. Bisgrove, E. Verdin, and W. C. Greene
Prostratin Antagonizes HIV Latency by Activating NF-{kappa}B
J. Biol. Chem., October 1, 2004; 279(40): 42008 - 42017.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
O. Rohr, C. Marban, D. Aunis, and E. Schaeffer
Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells
J. Leukoc. Biol., November 1, 2003; 74(5): 736 - 749.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Barat and M. J. Tremblay
Engagement of CD43 Enhances Human Immunodeficiency Virus Type 1 Transcriptional Activity and Virus Production That Is Induced upon TCR/CD3 Stimulation
J. Biol. Chem., August 2, 2002; 277(32): 28714 - 28724.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement